Skip to Content

93 7351 93 7351 (Lansoprazole Delayed Release 30 mg)

Pill with imprint 93 7351 93 7351 is Gray & Pink, Capsule-shape and has been identified as Lansoprazole Delayed Release 30 mg. It is supplied by Teva Pharmaceuticals USA.

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7351 93 7351

Lansoprazole delayed release 30 mg 93 7351 93 7351
Lansoprazole delayed release 30 mg 93 7351 93 7351
Lansoprazole delayed release 30 mg 93 7351 93 7351
Lansoprazole delayed release 30 mg 93 7351 93 7351
Lansoprazole delayed release 30 mg 93 7351 93 7351

Lansoprazole Delayed Release

Imprint
93 7351 93 7351
Strength
30 mg
Color
Gray & Pink
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
ferrosoferric oxide, hypromellose 2910 (6 mPa.s), magnesium carbonate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, propylene glycol, ferric oxide red, shellac, sucrose, corn starch, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-7351 Teva Pharmaceuticals USA, Inc.
42291-0365 AvKare, Inc.
54868-6086 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.